We advocate for compounding pharmacies and facilities on a range of state and federal issues affecting patient access to compounded medications. We represent pharmacists and technicians in both traditional 503A compounding pharmacies and 503B outsourcing facilities, as well as prescribers, patients, educators, and suppliers. We’re 5,000 members strong and growing.
A big week for peptide compounding: APC met with the White House, briefed House staff, and responded to HHS’s new enforcement discretion policy.
DEA now allows pharmacies to deliver controlled substances to a practitioner’s office under a patient power of attorney. What compounders need to ...
Nominations are open for APC and Pharmacy Compounding Foundation committees for 2027. Apply by Nov. 20 to shape policy, education, and member ...
The Alliance for Pharmacy Compounding congratulates five newly elected and reelected Board of Directors members, serving from January 1, 2027.
HHS is allowing compounding of six peptides under interim enforcement discretion. APC explains the guardrails, limits, and what happens next.
.png?width=410&height=320&name=image-container%20(1).png)
.png?width=410&height=320&name=image-container%20(2).png)
.png?width=411&height=320&name=image-container%20(3).png)
.png?width=410&height=320&name=image-container%20(4).png)
.png)
.jpg?width=728&height=90&name=Is%20It%20Legit%20-%20Leaderboard%202026%20(002).jpg)
.png?width=17&height=16&name=folder%20(1).png){kind=small}
%20Pharma-GS.png)
